2m 2m 2m 2m 2m 2m 2m
APIMEDS PHARM (APUS)
NYSE
$0.73-$0.003 (-0.41%)
Price as of Jul 14, 2026 4:01 AM EDT- $10.9MMarket Cap
- -95.99%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
APIMEDS PHARM (APUS)
$0.73-$0.003 (-0.41%)
APUS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.74 | ||
Change | +$0.02 (+2.36%) | ||
Open | $0.72 | ||
High | $0.74 | ||
Low | $0.71 | ||
Previous Close | $0.72 | ||
Volume | 63,431 | ||
30-Day Average Volume | 156,574 | ||
1-Week Change | -14.30% | ||
1-Month Change | -42.42% | ||
1-Year Change | -95.99% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 15.1M | ||
Total Assets | $141.2M | ||
Market Cap | $10.9M | ||
Enterprise Value | $18.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$35.1M | ||
Free Cash Flow | -$2.1M | ||
EBIT | -$35.1M | ||
EBITDA | -$35.0M | ||
Net Working Capital | -$1.4M | ||
EPS | -$2.26 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/26/2026 | ||
Earnings & Revenue